LDS/Medical Tests/LAMP2 Gene Mutation Analysis

LAMP2 Gene Mutation Analysis

The LAMP2 gene is located in the long (q) arm of the X chromosome at position 24 and encodes for lysosome-associated membrane protein 2 (LAMP2). This protein functions in the protection, maintenance, and adhesion of the lysosome. It may also play a role in tumor cell metastasis. The isoforms of the LAMP-2 protein are LAMP-2A, LAMP-2B, and LAMP-2C. These isoforms are found in different tissues throughout the body. LAMP-2A is highly expressed in the placenta, lung, and liver, while LAMP-2B is highly expressed in skeletal muscle. Nonsense, frameshift, splicing and missense mutations have been identified in the LAMP2 gene.

Mutation in the LAMP2 gene that result in LAMP-2 protein deficiency cause Glycogen storage disorder IIb also called Danon disease. The disease is inherited as a semi-dominant X-linked disorder and typically males are more severely affected than females. Patients with Danon disease typically show a triad of findings: hypertrophic cardiomyopathy, muscle weakness, and mental retardation. Other organs such as the liver and retina may be involved. Due to its rapid progression, heart transplantation is the preferred treatment once heart failure has been diagnosed.

  • Diagnostic confirmation of Glycogen storage disorder IIb or Danon disease
  • Carrier screening for relatives and those with the family history
  • Prenatal carrier screening for those with the family history
Mutation or pathogenic variants in LAMP2 gene. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative for mutations analyzed (No pathogenic variant or mutation detected)

Targeted variant analysis by next generation sequencing. Sequence analysis of the entire coding region or selected exon, deletions or duplications by PCR or multiplex ligation-dependent probe amplification (MLPA) analysis.

Whole blood (EDTA), buccal swab.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Acid maltase activity, muscle biopsy with immunohistochemistry, creatine kinase (CK), CK-MB, lactate dehydrogenase (LDH), troponin T, myosin light chain-1 (MLC-1), electrocardiogram, cardiac catheterization and magnetic resonance imaging (MRI).
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Circ J. 2009 Feb;73(2):376-80. [PMID: 19057086]
  • Circ Cardiovasc Genet. 2010;3:129-37. [PMID: 20173215]
  • Congenit Heart Dis. 2007;2:404-9. [PMID: 18377432]
  • Circulation. 2005;112:1612-7. [PMID: 16144992]
  • Ophthalmic Genet. 2019 Jun;40(3):227-236. [PMID: 31264915]
  • Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/LAMP2#
  • Fetal and Neonatal Physiology. In: Pathophysiology of Cardiomyopathies, Chapter 154. 2017; 1563–1575.e4. doi:10.1016/b978-0-323-35214-7.00154-2
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login